Chemring Group PLC has announced that three directors of the company, Andrew Lewis, Sarah Ellard, and Michael Ord, have exercised options granted under the Chemring Group 2018 UK Sharesave Plan. Andrew Lewis exercised 8,910 options, resulting in a beneficial interest of 315,717 shares. Sarah Ellard also exercised 8,910 options, resulting in a beneficial interest of 246,243 shares. Michael Ord exercised 16,853 options, resulting in a beneficial interest of 576,906 shares. The transactions were conducted on 3 October 2023 in the UK.